These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 35267469)
21. Transperineal retropubic approach in total pelvic exenteration for advanced and recurrent colorectal and anal cancer involving the penile base: technique and outcomes. Mehta AM; Hellawell G; Burling D; Littler S; Antoniou A; Jenkins JT Tech Coloproctol; 2018 Sep; 22(9):663-671. PubMed ID: 30306276 [TBL] [Abstract][Full Text] [Related]
22. Outcomes of pelvic exenteration for locally advanced primary rectal cancer: Overall survival and quality of life. Quyn AJ; Austin KK; Young JM; Badgery-Parker T; Masya LM; Roberts R; Solomon MJ Eur J Surg Oncol; 2016 Jun; 42(6):823-8. PubMed ID: 26947962 [TBL] [Abstract][Full Text] [Related]
23. Advances in surgical management for locally recurrent rectal cancer: How far have we come? Lee DJ; Sagar PM; Sadadcharam G; Tan KY World J Gastroenterol; 2017 Jun; 23(23):4170-4180. PubMed ID: 28694657 [TBL] [Abstract][Full Text] [Related]
24. Selection criteria for the radical treatment of locally advanced rectal cancer. Davies ML; Harris D; Davies M; Lucas M; Drew P; Beynon J Int J Surg Oncol; 2011; 2011():678506. PubMed ID: 22312517 [TBL] [Abstract][Full Text] [Related]
25. Management strategies for patients with advanced rectal cancer and liver metastases using modified Delphi methodology: results from the PelvEx Collaborative. PelvEx Collaborative Colorectal Dis; 2020 Sep; 22(9):1184-1188. PubMed ID: 32043753 [TBL] [Abstract][Full Text] [Related]
26. Cystoprostatectomy versus prostatectomy alone for locally advanced or recurrent pelvic cancer. Turner GA; Harris CA; Eglinton TW; Wakeman CJ; Kueppers F; Dixon L; Dobbs BR; Frizelle FA ANZ J Surg; 2016; 86(1-2):54-8. PubMed ID: 25113257 [TBL] [Abstract][Full Text] [Related]
27. Survival and morbidity outcomes after pelvic exenteration for pelvic sarcoma: an institutional series. Lee PJ; Meshkat B; Sasidharan P; Zahid A; Coker DJ; Solomon MJ ANZ J Surg; 2022 May; 92(5):1038-1043. PubMed ID: 34661958 [TBL] [Abstract][Full Text] [Related]
29. Extended surgery and pelvic exenteration for locally advanced rectal cancer. What are the limits? Smith JD; Paty PB Acta Chir Iugosl; 2010; 57(3):23-7. PubMed ID: 21066979 [TBL] [Abstract][Full Text] [Related]
31. Morbidity and outcome of pelvic exenteration in locally advanced pelvic malignancies. Ramamurthy R; Duraipandian A Indian J Surg Oncol; 2012 Sep; 3(3):231-5. PubMed ID: 23997512 [TBL] [Abstract][Full Text] [Related]
32. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma. Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945 [TBL] [Abstract][Full Text] [Related]
33. Extended sacropelvic resection for locally recurrent rectal cancer: can it be done safely and with good oncologic outcomes? Colibaseanu DT; Dozois EJ; Mathis KL; Rose PS; Ugarte ML; Abdelsattar ZM; Williams MD; Larson DW Dis Colon Rectum; 2014 Jan; 57(1):47-55. PubMed ID: 24316945 [TBL] [Abstract][Full Text] [Related]
34. The Evolution of Pelvic Exenteration Practice at a Single Center: Lessons Learned from over 500 Cases. Koh CE; Solomon MJ; Brown KG; Austin K; Byrne CM; Lee P; Young JM Dis Colon Rectum; 2017 Jun; 60(6):627-635. PubMed ID: 28481857 [TBL] [Abstract][Full Text] [Related]
35. Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer. Bhangu A; Ali SM; Brown G; Nicholls RJ; Tekkis P Ann Surg; 2014 Feb; 259(2):315-22. PubMed ID: 23478530 [TBL] [Abstract][Full Text] [Related]
36. Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer. Platt E; Dovell G; Smolarek S Tech Coloproctol; 2018 Nov; 22(11):835-845. PubMed ID: 30506497 [TBL] [Abstract][Full Text] [Related]
38. Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy. Williams M; Perera M; Nouhaud FX; Coughlin G Investig Clin Urol; 2021 Jan; 62(1):111-120. PubMed ID: 33381928 [TBL] [Abstract][Full Text] [Related]
39. Determinants of survival following pelvic exenteration for primary rectal cancer. Radwan RW; Jones HG; Rawat N; Davies M; Evans MD; Harris DA; Beynon J; Br J Surg; 2015 Sep; 102(10):1278-84. PubMed ID: 26095525 [TBL] [Abstract][Full Text] [Related]